The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve | Zendy

Anne Musters | Zendy; Madelon van Wely | Zendy; Sebastiaan Mastenbroek | Zendy; Eugenie M. Kaaijk | Zendy; Sjoerd Repping | Zendy; F. van der Veen | Zendy; Monique H. Mochtar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve

Author(s) -

Anne Musters,

Madelon van Wely,

Sebastiaan Mastenbroek,

Eugenie M. Kaaijk,

Sjoerd Repping,

F. van der Veen,

Monique H. Mochtar

Publication year - 2011

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/der371

Subject(s) - controlled ovarian hyperstimulation , embryo transfer , antral follicle , miscarriage , ovarian reserve , gynecology , embryo quality , in vitro fertilisation , pregnancy rate , single embryo transfer , live birth , pregnancy , medicine , confidence interval , luteinizing hormone , andrology , obstetrics , biology , follicular phase , hormone , infertility , genetics

Poor ovarian response is a common clinical problem, affecting up to 26% of IVF cycles. For these women, addition of recombinant luteinizing hormone (rLH) to ovarian hyperstimulation with recombinant FSH has a beneficial effect on ongoing pregnancy rates, but its effect on the yield of top-quality embryos is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research